Pure form Sealed in dry,2-8°C
In solvent -20°C:3-6个月-80°C:12个月
1 mM
5 mM
10 mM
7.14mL
1.43mL
0.71mL
35.68mL
3.57mL
71.36mL
14.27mL
[1]Stoessel D, et al. Promising Metabolite Profiles in the Plasma and CSF of Early Clinical Parkinson's Disease. Front Aging Neurosci. 2018 Mar 5;10:51.
[2]Güney M, et al. Synthesis and carbonic anhydrase inhibitory properties of novel uracil derivatives. Bioorg Med Chem Lett. 2015 Aug 15;25(16):3261-3.